GLP-1s and neurotech are colliding over chronic pain
Fifty million Americans wake up in chronic pain every day. Not soreness. Not the dull ache of a hard week. Pain that has dismantled careers, ended marriages, and driven people, my patients, over 25 years, to suicide, overdose, and a slow erasure of self. I trained at USC and UCLA, spent three decades in interventional pain management, and I can tell you with clinical certainty: the system we built to …
GLP-1s and neurotech are colliding over chronic pain
